Raoultella planticola (formerly Klebsiella planticola) is a Gram-negative bacterium that has been rarely reported in association with human infection. Here we describe a case of cholangitis complicated with septic shock caused by R. planticola in an immunocompromised patient with advanced cancer who underwent endoscopic retrograde cholangiopancreatography to extract common bile duct stones. The infection was cleared by piperacillin-tazobactam treatment.
Introduction
Raoultella planticola was first described in 1981 as Klebsiella planticola (Bagley et al., 1981) . In 1983, Klebsiella trevisanii was also reported as a new species (Ferragut et al., 1983) . These two species were recognized as K. planticola in 1986, based on phenotypic and genetic similarities . Drancourt et al. (2001) analysed the sequence of the 16S rRNA and rpoB genes and renamed K. planticola as R. planticola.
Case report
A 65-year-old Japanese man with a history of advanced apocrine adenocarcinoma of the right neck with right cervical lymphadenopathy and multiple bone metastases had been awaiting chemotherapy. During routine followup, he was found to have abnormal liver function tests (Table 1) , with gallbladder and common bile duct stones, and admitted to the Department of Medicine, Division of Gastroenterology, at the Jichi Medical University Hospital for further evaluation. He was asymptomatic. The patient's clinical course is summarized in Table 2 . After admission, the patient was observed closely, with fluid administration for the elevated liver enzymes. On the fifth hospital day, he underwent the first endoscopic retrograde cholangiopancreatography (ERCP) to extract multiple common bile duct stones. Several stones in the common bile duct were removed successfully. The patient continued to be observed as an inpatient. On the eighth hospital day, a follow-up imaging study using contrast material through the endoscopic nasobiliary drainage (ENBD) tube revealed that there was a residual 20 mm stone at the junction of the cystic, hepatic and common bile ducts which was too large for extraction by ERCP. On the 13th hospital day, extracorporeal shock wave lithotripsy (ESWL) was performed to break up the stone before the second ERCP on the same day. The stone at the junction as well as several other large stones in the common bile duct were removed successfully. However, there were still multiple residual stones in the gallbladder after the procedure. Cholecystectomy was considered but deferred due to his advanced apocrine adenocarcinoma. On the 15th hospital day, a follow-up ENBD tube imaging study with contrast material was performed. It revealed more stones in the common bile duct and a third ERCP was scheduled. On the 18th hospital day, the patient had a fever to 39.9 uC with chills, a blood pressure of 86/46 mmHg and a heart rate of 108 beats min 21 in the morning. Fluid resuscitation was initiated and his blood pressure immediately returned to 110/ 58 mmHg. Antimicrobial therapy with cefoperazone-sulbactam 1 g every 12 h was started for presumed acute cholangitis. The urgent third ERCP was performed in the afternoon, and no stones were found in the common bile duct despite the previous ENBD tube imaging study results. Only debris was removed during this procedure. Two sets of blood cultures were obtained from the peripheral veins after the procedure was completed. Approximately 6 h after the third ERCP, the patient developed hypotension with a blood pressure of 78/ 46 mmHg, which was treated with intravenous fluids and dopamine therapy. Physical examination showed that his temperature was 39.0 u C and his heart rate was 103 beats min
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; the abdomen did not reveal any tenderness or Murphy's sign. The rest of the examination was unremarkable. The results of the laboratory tests obtained during that time are shown in Table 1 . On the 19th hospital day, a repeat CT scan of the abdomen confirmed a residual stone in the common bile duct and a dilated common bile duct. Antimicrobial therapy was changed to meropenem 0.5 g every 8 h and a fourth ERCP was performed. The stone in the common bile duct was removed and a stent was placed endoscopically to relieve the obstruction. One set of blood cultures became positive with Gram-negative rods on the 20th hospital day, while the other set was negative. The patient improved significantly and blood pressure became stabilized on the following day with this therapy. The Gram-negative rod was identified as R. planticola using the automated identification system VITEK 2 with GN Identification Card (bioMérieux) with a probability of .95 %. Susceptibility testing was performed with the automated system VITEK 2 with AST-N127 (bioMérieux) for Gram-negative organisms on the basis of the recommended protocol (Clinical and Laboratory Standards Institute, M100-S16, 2006). Susceptibility testing showed that the isolate was susceptible to most of the agents tested (Table 3) . Given the susceptibility testing results, meropenem was no longer indicated for treatment. Piperacillin/ tazobactam 4.5 g every 6 h was chosen for the rest of the course since the patient was immunocompromised with advanced cancer. Clinical signs and symptoms improved, and he was transferred to another hospital after receiving a total of 9 days of therapy with meropenem and piperacillin-tazobactam.
Discussion
R. planticola was originally reported as being isolated from soil and water in the environment (Bagley et al., 1981; Ferragut et al., 1983) . In more recent studies, R. planticola has been found in humans. Sources of clinical isolates of R. planticola have included sputum, urine, faeces, wounds and bile (Mori et al., 1989; Podschun et al., 1998; Freney et al., 1986) .
To our knowledge, only six cases of human infections with R. planticola, including the current case, have been reported so far. These cases are summarized in Table 4 . Although the case reports are limited, there are some common features of clinical manifestations due to R. planticola infection. First, there are two case reports of skin, soft tissue and bone infections (O'Connell et al., 2010; Wolcott & Dowd 2010) . These infections were most likely due to the wide distribution of this organism in the environment such as in water and soil (Bagley et al., 1981; Ferragut et al., 1983) . Second, four out of six patients were reported to have immunocompromised conditions (Freney et al., 1984 (Freney et al., , 1986 Alves et al., 2007) , although Freney et al. (1984 Freney et al. ( , 1986 did not provide the details of comorbidities. 
*R, resistant; S, susceptible. Third, four out of six patients had undergone invasive procedures.
The patient in the current case was immunocompromised with metastatic neck cancer, and developed an infection with R. planticola after undergoing ERCP. We describe a clinical case of presumed cholangitis with septic shock caused by R. planticola, although this patient did not present with all five components of Reynolds' pentad. Cholangitis was suspected as the most likely cause of septic shock since no other source of shock was found. Given the immunocompromised condition of the patient, with clinical shock, and positive blood cultures obtained during shock, the diagnosis of bacteraemia rather than skin contamination was established. It is assumed that this patient was colonized with R. planticola in the gastrointestinal tract before the ERCP.
In conclusion, R. planticola can cause cholangitis among immunocompromised patients. Invasive medical procedures can be major risk factors for active infection due to this organism. Therefore, it is prudent to consider the possibility of R. planticola as a causative agent among those with the above risk factors.
